Vista Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46,517
Closed -$1.19M 183
2025
Q3
$1.19M Hold
46,517
0.41% 71
2025
Q2
$1.13M Hold
46,517
0.42% 70
2025
Q1
$1.18M Hold
46,517
0.46% 66
2024
Q4
$1.23M Hold
46,517
0.47% 65
2024
Q3
$1.35M Hold
46,517
0.51% 66
2024
Q2
$1.3M Hold
46,517
0.53% 63
2024
Q1
$1.29M Buy
+46,517
New +$1.29M 0.53% 57
2020
Q1
Sell
-5,953
Closed -$221K 135
2019
Q4
$221K Sell
5,953
-1
-0% -$36 0.17% 133
2019
Q3
$203K Buy
+5,954
New +$217K 0.17% 131

Other funds holding PFE

Vista Investment Management's PFE Position: Q4 2025 in Review

Vista Investment Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 46,517 shares — an estimated $1.19M sold.

Vista Investment Management first reported a position in PFE in Q3 2019 and held it in 9 quarters. The position peaked at $1.35M in Q3 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Vista Investment Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Vista Investment Management sold 46,517 Pfizer shares in Q4 2025, an estimated $1.19M.
  • Vista Investment Management first reported a position in Pfizer in Q3 2019 and held it in 9 quarters.
  • Vista Investment Management's Pfizer position peaked at $1.35M in Q3 2024.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Vista Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.